Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far. Glenmark Pharma is down 10 per cent for the week month period and 14.45 per ...

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

Aurobindo Pharma jumped 3.42% to Rs 1,119.55 after the pharma company said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban ...

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, reports successful trial results for BP16, a new drug showing promise ...

Earlier on Thursday, shares of pharma companies surged 7 per cent after the Trump administration exempted pharmaceuticals ...

Pharma stocks plummet as Trump threatens tariffs, impacting US-dependent companies and leading to market volatility.

Nifty Pharma fell nearly 5% on Friday, the most since June 4, after US President Donald Trump said that there will be tariffs ...

The Nifty Pharma index closed 1.21 per cent up at 21126.75. Benchmark NSE Nifty50 index ended up 414.46 points at 23851.65, ...